This results in more sustainable improvements with fewer side effects compared to traditional hormone therapies
Currently: BPC-157 is not FDA-approved There are no standardized treatment guidelines Long-term human safety data is lacking Large randomized clinical trials have not been completed Optimal dosing protocols have not been established Because most published research comes from animal studies, scientists cannot yet determine whether the same effects occur in humans
doi: 10.1016/j.gene.2019.05.019 202 ZhangYYanNWangXChangYWangY
#### Indications: **Vitamin B12 Deficiency:** Treatment of vitamin B12 deficiency due to malabsorption, dietary insufficiency, or increased physiological needs (e.g., pregnancy, lactation)
Safety Considerations Combining Wegovy and HCG is not recommended and lacks any clinical evidence base or regulatory approval
TB-500 also reorganizes collagen deposition, reducing scar tissue formation